Source link : https://www.newshealth.biz/health-news/efs-depends-on-residual-tumor-in-nsclc/
SAN DIEGO — The degree of event-free survival (EFS) after surgery in early-stage non–small cell lung cancer (NSCLC) depends on the amount of residual tumor, according to a post hoc analysis of the KEYNOTE-671 study. The authors also found that perioperative pembrolizumab (Keytruda, Merck) continued to show a benefit over placebo in their new results, […]
Author : News Health
Publish date : 2024-09-11 06:34:53
Copyright for syndicated content belongs to the linked Source.